ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,734, issued on Oct. 14, was assigned to JICHI MEDICAL UNIVERSITY (Tokyo).

"Ferroptosis inhibitor and use therefor" was invented by Hitoshi Osaka (Shimotsuke, Japan), Akihiko Miyauchi (Shimotsuke, Japan), Eriko Jimbo (Shimotsuke, Japan) and Mizuki Kobayashi (Shimotsuke, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a means whereby it is possible to clarify the mechanism of manifestation of symptoms, an illness, or dysfunction caused by mitochondrial dysfunction and prevent or treat symptoms, an illness, or dysfunction relating to the same mechanism of manifestation. One embodiment of the present invention relates...